The PE Ratio as of November 2024 (TTM) for Kodiak Sciences Inc. (KOD) is -1.70

According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.70. This represents a change of 94.35% compared to the average of -0.87 of the last 4 quarters.

Kodiak Sciences Inc. (KOD) Historical PE Ratio (quarterly & annually)

How has KOD PE Ratio performed in the past?

The mean historical PE Ratio of Kodiak Sciences Inc. over the last ten years is -19.37. The current -1.70 PE Ratio has changed 777.84% with respect to the historical average. Over the past ten years (40 quarters), KOD's PE Ratio was at its highest in in the September 2023 quarter at -0.47. The PE Ratio was at its lowest in in the December 2019 quarter at -45.52.

Kodiak Sciences Inc. (KOD) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kodiak Sciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kodiak Sciences Inc. (KOD) Average PE Ratio

How has KOD PE Ratio performed in the past?

The current PE Ratio of Kodiak Sciences Inc. (KOD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Kodiak Sciences Inc. (KOD) PE Ratio vs. Peers

How is KOD’s PE Ratio compared to its peers?

Kodiak Sciences Inc.’s PE Ratio is less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Eyenovia, Inc. (-0.20), less than Cognition Therapeutics, Inc. (-0.50), less than TransCode Therapeutics, Inc. (-0.38), greater than Assembly Biosciences, Inc. (-2.34), greater than Instil Bio, Inc. (-2.26), greater than Neoleukin Therapeutics, Inc. (-5.86), less than Spero Therapeutics, Inc. (21.41), less than CytomX Therapeutics, Inc. (5.48), greater than Checkpoint Therapeutics, Inc. (-3.48), less than Mustang Bio, Inc. (-0.32), less than Reviva Pharmaceuticals Holdings, Inc. (-1.19), less than Fortress Biotech, Inc. (-0.62), greater than Intercept Pharmaceuticals, Inc. (-91.78), greater than Madrigal Pharmaceuticals, Inc. (-14.57), less than Sarepta Therapeutics, Inc. (89.43), greater than Mirati Therapeutics, Inc. (-11.26), less than Biomea Fusion, Inc. (-1.62), greater than Stoke Therapeutics, Inc. (-6.11), greater than Akero Therapeutics, Inc. (-9.58), less than Homology Medicines, Inc. (-0.01), greater than Gossamer Bio, Inc. (-2.20),

Build a custom stock screener for Kodiak Sciences Inc. (KOD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kodiak Sciences Inc. (KOD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.